Vaxart, Inc. (VXRT)
Vaxart Market Cap: 87.69M for Dec. 9, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Bionano Genomics, Inc. | 16.99M |
| AIM ImmunoTech, Inc. | 1.123M |
| Perspective Therapeutics, Inc. | 186.96M |
| Protalix Biotherapeutics, Inc. | 140.34M |
| Armata Pharmaceuticals, Inc. | 217.62M |
Market Cap Related Metrics
| PS Ratio | 0.5626 |
| Price to Book Value | 3.278 |
| Price | 0.3653 |
| Earnings Yield | -60.83% |